Phoenixville, PA, United States of America

Kevin Pan


Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 108(Granted Patents)


Location History:

  • Wayne, PA (US) (2002 - 2006)
  • Shanghai, CN (2004 - 2006)
  • Phoenixville, PA (US) (2006 - 2013)

Company Filing History:


Years Active: 2002-2013

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Kevin Pan: A Pioneer in Melanocortin Receptor Modulation

Introduction

Kevin Pan is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds that target melanocortin receptors. With a total of 10 patents to his name, his work has the potential to address various metabolic, central nervous system, and dermatological disorders.

Latest Patents

One of Kevin Pan's latest patents involves the creation of 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators. This invention is directed towards novel compounds that can function as either agonists or antagonists of the melanocortin receptor. The compounds developed through this patent are particularly useful in treating a range of conditions, including obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, and various skin disorders. The potential applications of these compounds extend to treating complex health issues such as diabetic retinopathy, spinal cord injuries, and neurodegenerative disorders.

Career Highlights

Throughout his career, Kevin Pan has worked with notable companies in the pharmaceutical industry, including Ortho-McNeil Pharmaceutical Corporation and Johnson & Johnson Consumer Companies, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Kevin has collaborated with esteemed colleagues such as Louis J. Fitzpatrick and Allen B. Reitz. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his innovations.

Conclusion

Kevin Pan's work in developing melanocortin receptor modulators represents a significant advancement in the treatment of various health conditions. His innovative approach and dedication to research continue to pave the way for future discoveries in pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…